Fig. 5
From: Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma
Genetic mutations of CELSR2 and its associations with OS in HCC patients (cBioPortal). a Oncoprint of CELSR2 alterations in HCC. The overview of genomic alterations showed that the alteration rate of CELSR2 was 8%. b Mutation types of CELSR2 gene in HCC patients. c Network view of CELSR2 and its altered neighboring genes in HCC. d GO functional enrichment and KEGG pathway analyses of CELSR2 and its frequently altered neighboring genes